Skip to main content
# Title Department Research Year
51 Thiadiazine-2-thione derivatives as new cell- cycle inhibitors Department of Medicinal Chemistry 2023
52 LIPID NANOPARTICLES TECHNOLOGY IN VACCINES; SHAPING THE FUTURE OF PROPHYLACTIC MEDICINE Department of Industrial Pharmacy 2023
53 Phytochemical Investigation, In silico/In vivo Analgesic, and Anti-inflammatory Assessment of the Egyptian Cassia occidentalis L. Department of Pharmacognosy 2023
54 Tailoring of novel azithromycin loaded zinc oxide nanoparticles for wound healing Department of Microbiology and Immunology 2022
55 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Department of Medicinal Chemistry 2022
56 New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents Department of Pharmaceutical Organic Chemistry 2022
57 Novel Azine Linked Hybrids of 2-indolinone and Thiazolodinone Scaffolds as CDK2 Inhibitors with Potential Anticancer Activity: In Silico Design, Synthesis, Biological, Molecular Dynamics and Binding Free Energy Studies Department of Medicinal Chemistry 2022
58 Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies Department of Pharmaceutical Organic Chemistry 2022
59 Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice Department of Pharmacology 2022
60 New 1, 2, 4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity Department of Pharmaceutical Organic Chemistry 2022